Acute and Sub-chronic Toxicity of Indole Alkaloids Extract from Leaves of Alstonia scholaris (L.) R. Br. in Beagle Dogs.
Yun-Li ZhaoMin SuJian-Hua ShangXia WangGuang-Lei BaoJia MaQing-Di SunFang YuanJing-Kun WangXiao-Dong LuoPublished in: Natural products and bioprospecting (2020)
Alstonia scholaris (L.) R. Br., an evergreen tropical plant rich in indole alkaloids with significant physiological activity, is traditionally used to treat respiratory diseases in China. This study was conducted to establish the toxicity profile of the alkaloid extract (TA) of A. scholaris leaves in non-rodents. After oral administration of a single dose (4 g/kg.bw), a number of transient symptoms, such as unsteady gait, drooling, emesis, and reddening of peri-oral mucosa, were observed, but no treatment-related mortality. A sub-chronic toxicity study with a range of doses of TA (20, 60 and 120 mg/kg.bw) was conducted for a 13-week treatment period, followed by 4-week recovery observation. Except for emesis and drooling in majority of animals in 120 mg/kg.bw treatment group, no clinical changes were observed in TA-treated animals. Data from electrocardiography, bone marrow, urine, fecal, hematology and clinical chemistry analyses were comparable between TA-treated and control animals. No significant differences in the relative organ weights and histopathological characteristics were evident between the TA-treated and control groups. Accordingly, the non-observed-adverse-effect-level (NOAEL) of TA was established as 120 mg/kg.bw. Our results add further knowledge to the safety database for indole alkaloid extracts from A. scholaris with potential utility as novel drug candidates.
Keyphrases
- oxidative stress
- bone marrow
- clinical trial
- emergency department
- drug induced
- cardiovascular disease
- electronic health record
- depressive symptoms
- climate change
- combination therapy
- physical activity
- artificial intelligence
- cardiovascular events
- extracorporeal membrane oxygenation
- machine learning
- deep learning
- big data
- brain injury
- respiratory failure
- smoking cessation
- data analysis
- respiratory tract
- drug discovery